Classification of Primary Immunodeficiencies

1973 ◽  
Vol 288 (18) ◽  
pp. 966-967 ◽  
Author(s):  
Max D. Cooper ◽  
W. Page Faulk ◽  
H. Hugh Fudenberg ◽  
Robert A. Good ◽  
Walter Hitzig ◽  
...  
1975 ◽  
Vol 86 (6) ◽  
pp. 988
Author(s):  
C. Pieraert ◽  
J.P. Farriaux ◽  
G. Fontaine

2019 ◽  
Vol 10 ◽  
Author(s):  
Jacques J. M. van Dongen ◽  
Mirjam van der Burg ◽  
Tomas Kalina ◽  
Martin Perez-Andres ◽  
Ester Mejstrikova ◽  
...  

2021 ◽  
Vol 41 (3) ◽  
pp. 666-679 ◽  
Author(s):  
Stuart G. Tangye ◽  
Waleed Al-Herz ◽  
Aziz Bousfiha ◽  
Charlotte Cunningham-Rundles ◽  
Jose Luis Franco ◽  
...  

AbstractThe most recent updated classification of inborn errors of immunity/primary immunodeficiencies, compiled by the International Union of Immunological Societies Expert Committee, was published in January 2020. Within days of completing this report, it was already out of date, evidenced by the frequent publication of genetic variants proposed to cause novel inborn errors of immunity. As the next formal report from the IUIS Expert Committee will not be published until 2022, we felt it important to provide the community with a brief update of recent contributions to the field of inborn errors of immunity. Herein, we highlight studies that have identified 26 additional monogenic gene defects that reach the threshold to represent novel causes of immune defects.


2020 ◽  
Vol 40 (7) ◽  
pp. 1026-1037
Author(s):  
Vassilios Lougaris ◽  
Andrea Pession ◽  
Manuela Baronio ◽  
Annarosa Soresina ◽  
Roberto Rondelli ◽  
...  

Abstract Primary immunodeficiencies (PIDs) are heterogeneous disorders, characterized by variable clinical and immunological features. National PID registries offer useful insights on the epidemiology, diagnosis, and natural history of these disorders. In 1999, the Italian network for primary immunodeficiencies (IPINet) was established. We report on data collected from the IPINet registry after 20 years of activity. A total of 3352 pediatric and adult patients affected with PIDs are registered in the database. In Italy, a regional distribution trend of PID diagnosis was observed. Based on the updated IUIS classification of 2019, PID distribution in Italy showed that predominantly antibody deficiencies account for the majority of cases (63%), followed by combined immunodeficiencies with associated or syndromic features (22.5%). The overall age at diagnosis was younger for male patients. The minimal prevalence of PIDs in Italy resulted in 5.1 per 100.000 habitants. Mortality was similar to other European registries (4.2%). Immunoglobulin replacement treatment was prescribed to less than one third of the patient cohort. Collectively, this is the first comprehensive description of the PID epidemiology in Italy.


Cancer ◽  
1980 ◽  
Vol 46 (4) ◽  
pp. 692-699 ◽  
Author(s):  
Glauco Frizzera ◽  
Juan Rosai ◽  
Louis P. Dehner ◽  
Beatrice D. Spector ◽  
John H. Kersey

Sign in / Sign up

Export Citation Format

Share Document